The National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for IOL Chemicals and Pharmaceuticals Limited's products.
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
They will commercialize molnupiravir in the international markets
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The company expects revenue growth of 10-15 per cent in the US
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
Subscribe To Our Newsletter & Stay Updated
